Sonic Healthcare (SKHHY) Stock Price, News & Analysis

Company Overview

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Key Stats

• Today's Range: $16.23 to $17.05
• 50-Day Range: $15.89 to $18.60
• 52-Week Range: $15.24 to $20.59
• Volume: 51,724 shs
• Average Volume: 42,075 shs
• Market Capitalization: $7.83 billion
• P/E Ratio: N/A
• Dividend Yield: 3.07%
• Price Target: $28.10
• Consensus Rating: Hold

Sonic Healthcare Stock Analysis - MarketRank™

Sonic Healthcare scored higher than 73% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Sonic Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Sonic Healthcare has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 17.19%

Earnings Growth

Earnings for Sonic Healthcare are expected to grow by 17.19% in the coming year, from $0.64 to $0.75 per share.

Price to Book Value per Share Ratio

Sonic Healthcare has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Sonic Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Sonic Healthcare has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sonic Healthcare has recently decreased by 96.88%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Sonic Healthcare pays a meaningful dividend of 3.13%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sonic Healthcare does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Sonic Healthcare will have a dividend payout ratio of 66.67% next year. This indicates that Sonic Healthcare will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the float of Sonic Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Sonic Healthcare has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sonic Healthcare has recently decreased by 96.88%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.97

News Sentiment

Sonic Healthcare has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sonic Healthcare this week, compared to 0 articles on an average week.

MarketBeat Follows

1 people have added Sonic Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sonic Healthcare insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.01% of the stock of Sonic Healthcare is held by institutions.

SKHHY Stock Analysis - Frequently Asked Questions

How have SKHHY shares performed this year?

Sonic Healthcare's stock was trading at $16.68 at the beginning of 2025. Since then, SKHHY shares have decreased by 2.3% and is now trading at $16.30.
View the best growth stocks for 2025 here.

How do I buy shares of Sonic Healthcare?

Shares of SKHHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Record date for 3/31 Dividend: 3/06/2025
• Ex-Dividend for 3/31 Dividend: 3/06/2025
• Today: 3/27/2025
• Dividend Payable: 3/31/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private households
• Sub-Industry: Health Services
• Current Symbol: OTCMKTS:SKHHY
• Previous Symbol: OTCMKTS:SKHHY
• CIK: N/A
• Web: www.sonichealthcare.com
• Phone: (129) 855-5444
• Fax: 61-2-9878-5066
• Employees: 41,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $28.10
• High Stock Price Target: $28.10
• Low Stock Price Target: $28.10
• Potential Upside/Downside: +72.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $5.94 billion
• Price / Sales: 1.32
• Cash Flow: $0.88 per share
• Price / Cash Flow: 18.46
• Book Value: $11.33 per share
• Price / Book: 1.44

Miscellaneous

• Outstanding Shares: 480,404,000
• Free Float: N/A
• Market Cap: $7.83 billion
• Optionable: Not Optionable
• Beta: N/A